Samsung Life Science Fund
Overview
Samsung Life Science Fund is a corporate venture fund that invests in innovative biotech companies with promising technologies in areas including gene therapy, antibody-drug conjugates (ADCs), and AI-based drug discovery.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Generate Biomedicines | Dec 2024 | Corporate Funding | Co-investor |
| BrickBio, Inc. | Mar 2024 | VC Round | Co-investor |
| Latus Bio | May 2026 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Samsung Life Science Fund based?
Samsung Life Science Fund is headquartered in Incheon, South Korea.
When was Samsung Life Science Fund founded?
Samsung Life Science Fund was founded in 2021.
How many portfolio companies does Samsung Life Science Fund have?
Samsung Life Science Fund has 5 portfolio companies in Caplight's dataset.
What are some companies in Samsung Life Science Fund's portfolio?
Portfolio companies visible on Caplight include Generate Biomedicines, BrickBio, Inc., Latus Bio.
What was Samsung Life Science Fund's most recent investment shown here?
Samsung Life Science Fund's most recent investment in this portfolio sample was in Latus Bio in 2026.
What sectors does Samsung Life Science Fund focus on?
Samsung Life Science Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Samsung Life Science Fund focus on?
Stage focus information for Samsung Life Science Fund is not publicly available.
What is Samsung Life Science Fund's AUM?
Samsung Life Science Fund's assets under management are estimated between $165.5M and $180.0M.